Precision radiation medicine company Elekta AB (STO:EKTAB) announced on Monday the award of a group purchasing agreement for full line radiation oncology products and services to Premier.

Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,000 US hospitals and 175,000 other providers to transform healthcare.

Effective 1 September 2019, this new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for linear accelerators (linacs), Elekta Unity MR-linac, oncology informatics and services. The agreement implies that Premier will be the exclusive provider of precision radiation solutions to its extensive network of healthcare systems, hospitals and clinics.

This five-year sole source agreement with Elekta, effective from 1 September 2019, will enable Premier's members to begin purchasing Elekta's advanced oncology solutions, including Elekta Unity, a state-of-the-art MR-linac; Leksell Gamma Knife, bringing precision radiation medicine to the treatment of brain metastasis, as well as other brain tumours and functional brain disorders; Versa HD, a highly versatile, all-in-one radiotherapy system that overcomes the complexity of stereotactic treatments with high definition dynamic radiosurgery (HDRS); Elekta Infinity, a multifunctional platform, combining superior dose conformance and advanced image guidance; MOSAIQ Plaza, Elekta's patient-centric, integrative software suite and Elekta Care, a proactive services programme that helps customers deliver exceptional care.

Elekta Unity has CE mark and 510(k) clearance but is not available in all markets, the company added.